Jonine Figueroa
#49,438
Most Influential Person Now
American cancer epidemiologist
Jonine Figueroa's AcademicInfluence.com Rankings
Jonine Figueroamedical Degrees
Medical
#1967
World Rank
#2355
Historical Rank
#437
USA Rank
Epidemiology
#807
World Rank
#842
Historical Rank
#118
USA Rank
Download Badge
Medical
Jonine Figueroa's Degrees
- PhD Epidemiology Johns Hopkins University
Why Is Jonine Figueroa Influential?
(Suggest an Edit or Addition)According to Wikipedia, Jonine Figueroa is an American epidemiologist specializing in breast cancer epidemiology. She is a senior investigator and distinguished scholar in the integrative tumor epidemiology branch at the National Cancer Institute. She was previously a tenured professor and chair of molecular epidemiology and global cancer prevention at the University of Edinburgh.
Jonine Figueroa's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Large-scale genotyping identifies 41 new loci associated with breast cancer risk (2013) (1063)
- Association analysis identifies 65 new breast cancer risk loci (2017) (922)
- Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival (2008) (605)
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (2018) (559)
- MicroRNA Related Polymorphisms and Breast Cancer Risk (2014) (557)
- Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. (2011) (536)
- Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer (2013) (534)
- Detectable clonal mosaicism and its relationship to aging and cancer (2012) (512)
- Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer (2015) (502)
- Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants (2015) (471)
- Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018. (2018) (431)
- A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci (2010) (423)
- Genome-wide association studies identify four ER negative–specific breast cancer risk loci (2013) (411)
- RAD51B in Familial Breast Cancer (2016) (366)
- Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. (2020) (322)
- Large-scale genomic analyses link reproductive ageing to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair (2015) (308)
- Genome-wide association analysis identifies three new breast cancer susceptibility loci (2012) (291)
- Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States. (2016) (250)
- Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer (2017) (244)
- Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. (2013) (225)
- Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent (2016) (205)
- Polymorphisms in GSTT1, GSTZ1, and CYP2E1, Disinfection By-products, and Risk of Bladder Cancer in Spain (2010) (192)
- Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. (2011) (192)
- Identification of Novel Genetic Markers of Breast Cancer Survival (2015) (185)
- A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. (2012) (182)
- PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS (2016) (174)
- CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. (2012) (164)
- Breast cancer in Sub-Saharan Africa: opportunities for prevention (2014) (160)
- Evidence of Gene–Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors (2013) (159)
- Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. (2016) (154)
- A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (149)
- Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. (2016) (146)
- Genome-wide association study identifies multiple loci associated with bladder cancer risk. (2014) (136)
- Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. (2015) (133)
- Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors (2016) (133)
- Large-Scale Evaluation of Candidate Genes Identifies Associations between VEGF Polymorphisms and Bladder Cancer Risk (2007) (130)
- Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 (2016) (122)
- Genetic variation in the base excision repair pathway and bladder cancer risk (2007) (121)
- Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. (2010) (119)
- 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. (2012) (115)
- Mosaic loss of chromosome Y is associated with common variation near TCL1A (2016) (114)
- Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. (2009) (113)
- Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (2014) (112)
- GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. (2011) (111)
- Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk (2014) (111)
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2019) (110)
- Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. (2013) (109)
- Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. (2015) (107)
- Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes. (2008) (105)
- Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. (2013) (104)
- Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis (2020) (104)
- Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia (2014) (103)
- Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study (2010) (100)
- A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. (2011) (97)
- The role of genetic breast cancer susceptibility variants as prognostic factors. (2012) (95)
- Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (95)
- Ski-interacting Protein Interacts with Smad Proteins to Augment Transforming Growth Factor-β-dependent Transcription* (2001) (94)
- Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. (2007) (93)
- Characterization of large structural genetic mosaicism in human autosomes. (2015) (91)
- Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. (2011) (90)
- Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. (2014) (88)
- Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. (2016) (87)
- Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium. (2018) (86)
- Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. (2015) (86)
- No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing (2016) (83)
- Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data (2016) (83)
- Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk (2012) (81)
- Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. (2018) (80)
- BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. (2016) (76)
- Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome (2016) (72)
- Tumor Intrinsic Subtype Is Reflected in Cancer-Adjacent Tissue (2014) (70)
- Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology. (2014) (69)
- Genetic modifiers of CHEK2*1100delC associated breast cancer risk (2016) (68)
- Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. (2012) (68)
- Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UK (2020) (68)
- BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. (2017) (67)
- Expression of TGF-β signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics (2010) (67)
- Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer (2015) (63)
- Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation (2016) (63)
- Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium (2014) (62)
- A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background (2010) (60)
- Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) (2012) (60)
- Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status (2012) (59)
- Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus (2016) (58)
- Relationship of Mammographic Density and Gene Expression: Analysis of Normal Breast Tissue Surrounding Breast Cancer (2013) (57)
- Cytoplasmic Estrogen Receptor in Breast Cancer (2011) (57)
- Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups (2016) (57)
- DNA Hypermethylation of ESR1 and PGR in Breast Cancer: Pathologic and Epidemiologic Associations (2009) (56)
- The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: A Unique Resource for Defining the “Molecular Histology” of the Breast (2012) (52)
- Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients (2017) (52)
- TGF-β Signaling Pathway and Breast Cancer Susceptibility (2011) (51)
- Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk. (2015) (51)
- GSTM 1 null and NAT 2 slow acetylation genotypes , smoking intensity and bladder cancer risk : results from the New England bladder cancer study and NAT 2 meta-analysis (2011) (50)
- Assessment of Automated Image Analysis of Breast Cancer Tissue Microarrays for Epidemiologic Studies (2010) (50)
- Factors contributing to delays in diagnosis of breast cancers in Ghana, West Africa (2017) (50)
- Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2 (2015) (50)
- Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast (2014) (49)
- A role for XRCC2 gene polymorphisms in breast cancer risk and survival (2011) (48)
- TNF polymorphisms and prostate cancer risk (2008) (47)
- Genetic predisposition to ductal carcinoma in situ of the breast (2016) (46)
- Genome-wide interaction study of smoking and bladder cancer risk. (2014) (46)
- Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer (2019) (45)
- Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes. (2010) (45)
- Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression (2009) (45)
- DNA mismatch repair gene MSH6 implicated in determining age at natural menopause (2013) (44)
- Genome-wide association study of germline variants and breast cancer-specific mortality (2019) (44)
- E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium (2018) (43)
- Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis (2015) (43)
- Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case–control study from Poland (2010) (43)
- The impact of the Covid-19 pandemic on breast cancer early detection and screening (2021) (42)
- Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study (2017) (42)
- Plasma Autoantibodies Associated with Basal-like Breast Cancers (2015) (42)
- ERβ splice variant expression in four large cohorts of human breast cancer patient tumors (2014) (42)
- Large-Scale Pathway-Based Analysis of Bladder Cancer Genome-Wide Association Data from Five Studies of European Background (2012) (42)
- Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium. (2014) (41)
- Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers (2012) (41)
- A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. (2014) (40)
- Effect modification of endocrine disruptors and testicular germ cell tumour risk by hormone-metabolizing genes. (2009) (39)
- Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case–control study (2016) (39)
- Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression. (2015) (39)
- Body mass index and breast cancer survival: a Mendelian randomization analysis (2017) (38)
- Likelihood ratio test for detecting gene (G)-environment (E) interactions under an additive risk model exploiting G-E independence for case-control data. (2012) (38)
- A versatile protein microarray platform enabling antibody profiling against denatured proteins (2013) (37)
- Relationship of Terminal Duct Lobular Unit Involution of the Breast with Area and Volume Mammographic Densities (2015) (37)
- Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status (2014) (37)
- Alcohol Consumption and Survival after a Breast Cancer Diagnosis: A Literature-Based Meta-analysis and Collaborative Analysis of Data for 29,239 Cases (2014) (36)
- A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6 q 14 and 20 q 11 (2012) (36)
- Urinary bisphenol A-glucuronide and postmenopausal breast cancer in Poland (2014) (36)
- Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium (2016) (35)
- An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. (2016) (35)
- Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk (2020) (35)
- Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women (2011) (34)
- Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms. (2015) (34)
- Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies. (2007) (34)
- Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population. (2015) (34)
- Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry. (2016) (33)
- Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21 (2016) (33)
- Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene‐Environment Interactions (2014) (33)
- Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer (2011) (33)
- Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus (2016) (32)
- Genetic variation in hormone metabolizing genes and risk of testicular germ cell tumors (2008) (31)
- Common germline polymorphisms associated with breast cancer-specific survival (2015) (31)
- Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study (2014) (31)
- Benign Breast Tissue Composition in Breast Cancer Patients: Association with Risk Factors, Clinical Variables, and Gene Expression (2014) (30)
- Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approaches (2020) (29)
- Quantitative assessment of miR34a as an independent prognostic marker in breast cancer (2014) (28)
- Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs) (2016) (27)
- A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020) (27)
- Prolactin Receptor Expression and Breast Cancer: Relationships with Tumor Characteristics among Pre- and Post-menopausal Women in a Population-Based Case–Control Study from Poland (2014) (27)
- Design considerations for identifying breast cancer risk factors in a population‐based study in Africa (2017) (27)
- Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes (2022) (27)
- Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1 (2013) (26)
- Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer (2013) (26)
- The human Ski-interacting protein functionally substitutes for the yeast PRP45 gene. (2004) (26)
- Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types (2015) (24)
- Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study. (2013) (23)
- Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland (2011) (23)
- Nonsteroidal anti‐inflammatory drugs and other analgesic use and bladder cancer in northern New England (2013) (23)
- Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium (2014) (23)
- High‐throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium (2016) (23)
- Breast cancer risk variants at 6 q 25 display different phenotype associations and regulate ESR 1 , RMND 1 and CCDC 170 (2016) (22)
- Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of Scottish cancer registry data (2019) (22)
- FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium (2014) (22)
- Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast (2014) (22)
- Reproductive factors and risk of breast cancer by tumor subtypes among Ghanaian women: A population‐based case–control study (2019) (22)
- Prediction and clinical utility of a contralateral breast cancer risk model (2019) (22)
- Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry. (2021) (22)
- Differential effects of the Ski-interacting protein (SKIP) on differentiation induced by transforming growth factor-beta1 and bone morphogenetic protein-2 in C2C12 cells. (2004) (21)
- The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. (2014) (21)
- Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression (2013) (21)
- The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (20)
- Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy (2015) (20)
- Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry (2016) (20)
- The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk (2013) (20)
- Quantitative analysis of TDLUs using adaptive morphological shape techniques (2013) (19)
- Gene–environment interactions involving functional variants: Results from the Breast Cancer Association Consortium (2017) (19)
- Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation (2018) (19)
- Skin lighteners and hair relaxers as risk factors for breast cancer: results from the Ghana breast health study (2018) (19)
- Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease (2016) (18)
- The BRCA2 c.68‐7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity (2018) (18)
- No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (2016) (18)
- Plasma Carotenoid- and Retinol-Weighted Multi-SNP Scores and Risk of Breast Cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (2013) (16)
- Genetic modifiers of CHEK 2 * 1100 delC-associated breast cancer risk (2017) (15)
- Smoking status, usual adult occupation, and risk of recurrent urothelial bladder carcinoma: data from The Cancer Genome Atlas (TCGA) Project (2016) (15)
- A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC 14 A 1 , a urea transporter gene on chromosome 18 q 12 . 3 (2011) (15)
- SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival (2015) (15)
- The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients (2015) (15)
- Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study (2012) (14)
- Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer. (2015) (14)
- Breast cancer susceptibility loci in association with age at menarche, age at natural menopause and the reproductive lifespan (2013) (14)
- Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus (2016) (14)
- Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. (2014) (14)
- Associations of fecal microbial profiles with breast cancer and nonmalignant breast disease in the Ghana Breast Health Study (2021) (14)
- Distinguishing between direct and indirect consequences of covid-19 (2020) (13)
- Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer (2017) (13)
- Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy (2016) (12)
- Large-scale genotyping identifies a new locus at 22q13.2 associated with female breast size (2013) (12)
- Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome (2013) (12)
- Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors (2017) (12)
- Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts (2020) (12)
- Pathway analysis of bladder cancer genome-wide association study identifies novel pathways involved in bladder cancer development (2016) (11)
- Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium (2015) (10)
- Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women (2021) (10)
- TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer (2017) (10)
- Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast (2017) (9)
- PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1 (2017) (9)
- Serum insulin‐like growth factor (IGF)‐I and IGF binding protein‐3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank (2018) (9)
- Recruiting population controls for case-control studies in sub-Saharan Africa: The Ghana Breast Health Study (2019) (9)
- Reproductive windows, genetic loci, and breast cancer risk. (2014) (8)
- Reply to ‘Mosaic loss of chromosome Y in leukocytes matters’ (2018) (8)
- Raised cardiovascular disease mortality after central nervous system tumor diagnosis: analysis of 171,926 patients from UK and USA (2021) (7)
- Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya (2021) (7)
- TGF-b Signaling Pathway and Breast Cancer Susceptibility (2011) (7)
- Involution of Breast Lobules, Mammographic Breast Density and Prognosis Among Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer Patients (2019) (7)
- Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers (2015) (7)
- Emerging Concepts in Breast Cancer Risk Prediction (2013) (7)
- Breast cancer risks associated with missense variants in breast cancer susceptibility genes (2021) (6)
- Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients (2015) (6)
- Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (6)
- Common breast cancer risk loci predispose to distinct tumor subtypes (2019) (6)
- Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue (2016) (6)
- Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element (2021) (6)
- Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (2018) (6)
- The Relation of Type 2 Diabetes and Breast Cancer Incidence in Asian, Hispanic and African American Populations-A Review. (2018) (6)
- Unraveling genes, hormones, and breast cancer. (2012) (5)
- The relationship between terminal duct lobular unit features and mammographic density among Chinese breast cancer patients (2019) (5)
- Might changes in diagnostic practice explain increasing incidence of brain and central nervous system tumours? A population-based study in Wales (UK) and the US. (2020) (5)
- Risk factors for breast cancer development by tumor characteristics among women with benign breast disease (2020) (5)
- Erratum: Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk (Nature Communications (2014) 5:5303 (DOI:10.1038/ncomms6303)) (2015) (5)
- CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers (2021) (5)
- Distinct reproductive risk profiles for intrinsic-like breast cancer subtypes: pooled analysis of population-based studies. (2022) (5)
- The Relationship between Type 2 Diabetes and Breast Cancer Incidence in Differing Ethnic Groups (2017) (4)
- Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing (2021) (4)
- Incorporating progesterone receptor expression into the PREDICT breast prognostic model. (2022) (4)
- Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups (2016) (4)
- Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) (2012) (4)
- The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health Study (2022) (4)
- The impact of measures to curb COVID-19 on patient attendance at 10 hospitals in Machakos County, Kenya (2021) (4)
- Genetic variation at CYP 3 A is associated with age at menarche and breast cancer risk : a case-control study (2014) (4)
- Fine mapping of 14q24.1 breast cancer susceptibility locus (2012) (4)
- Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast (2020) (3)
- Trends in excess cancer and cardiovascular deaths in Scotland during the COVID-19 pandemic 30 December – 20 April suggest underestimation of COVID-19 related deaths (2020) (3)
- Abstract 4682: Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease (2015) (3)
- Breast cancer gene expression datasets do not reflect the disease at the population level (2020) (3)
- Circulating tumor DNA is readily detectable among Ghanaian breast cancer patients supporting non-invasive cancer genomic studies in Africa (2020) (3)
- Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk (2020) (3)
- Tumor-Associated Stromal Cellular Density as a Predictor of Recurrence and Mortality in Breast Cancer: Results from Ethnically Diverse Study Populations (2021) (3)
- Relation of Quantitative Histologic and Radiologic Breast Tissue Composition Metrics with Invasive Breast Cancer Risk (2020) (3)
- Serum insulin-like growth factor ( IGF )-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women : The (2018) (2)
- A Genome-Wide Gene-Based Gene–Environment Interaction Study of Breast Cancer in More than 90,000 Women (2022) (2)
- PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (2022) (2)
- rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk (2016) (2)
- Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study (2017) (2)
- Two truncating variants in FANCC and breast cancer risk (2019) (2)
- Breast cancer gene expression datasets do not reflect the disease at the population level (2020) (2)
- Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya (2021) (2)
- Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium: Automated scoring of breast tumor TMAs (2014) (2)
- Breast Cancer Risk FromModifiable and Nonmodifiable Risk Factors AmongWhiteWomen in the United States (2016) (2)
- TRACKing Excess Deaths (TRACKED): an interactive online tool to monitor excess deaths associated with COVID-19 pandemic in the United Kingdom (2020) (2)
- Abstract 2201: Pathway analysis of breast cancer genome wide association study highlights three pathways and one canonical signaling cascade (2010) (2)
- A robust association test for detecting genetic variants with heterogeneous effects. (2015) (2)
- Abstract 4465: Breast cancer risk factor associations with breast tissue morphometry: results from the Komen for the Cure® Tissue Bank (2012) (2)
- Correction: Corrigendum: Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk (2015) (2)
- E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium (2018) (2)
- Annexin A 1 expression in a pooled breast cancer series (2)
- Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers (2012) (2)
- Abstract 385: Tamoxifen-resistant breast cancer: DNA methylation and expression of MAGED1 (2014) (2)
- Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status (2014) (1)
- Breast cancer incidence and survival in Scotland by socio-economic deprivation and tumour subtype (2022) (1)
- Discovery of structural deletions in breast cancer predisposition genes using whole genome sequencing data from > 2000 women of African-ancestry (2021) (1)
- Genome-wide association study of germline variants and breast cancer-speci fi c mortality (2019) (1)
- Abstract LB-178: Performance of breast cancer polygenic risk score (PRS) in a Ghanaian population (2019) (1)
- IDENTIFICATION AND REPLICATION OF THE INTERPLAY OF FOUR GENETIC HIGH‐RISK VARIANTS FOR URINARY BLADDER CANCER: MP54‐11 (2018) (1)
- Abstract P3-08-02: Common variants at 10p14 and 1p11.2 display heterogeneity in breast cancer associations by E-cadherin tumor tissue expression in two independent datasets (2012) (1)
- Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium (2015) (1)
- A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020) (1)
- Mosaic loss of chromosome Y is associated with common variation near TCL 1 A 1 2 (2016) (1)
- Smoking status, usual adult occupation, and risk of recurrent urothelial bladder carcinoma: data from The Cancer Genome Atlas (TCGA) Project (2016) (1)
- Syddansk Universitet Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12 p 11 locus (2016) (1)
- Rare germline copy number variants (CNVs) and breast cancer risk (2022) (1)
- Large-scale evaluation of candidate genes for cancer identifies common genetic variants in vascular endothelial growth factor associated with bladder cancer risk (2005) (1)
- Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (1)
- Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study (2014) (1)
- Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy (2015) (1)
- Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast (2020) (1)
- Abstract 2779: Relationship of mammographic density with breast cancer subtypes (2010) (1)
- Analysis of cancer diagnoses from 2015-2019 within Machakos County, Kenya, support establishment of Cancer Centre in 2019 likely changing referral patterns (2020) (1)
- Associations of Genetic Ancestry with Terminal Duct Lobular Unit Involution among Healthy Women. (2022) (1)
- Genetic predisposition to ductal carcinoma in situ of the breast (2016) (1)
- A novel functional variant in 8q24 is associated with regulation of prostate stem cell antigen (PSCA) gene expression and bladder cancer risk (2011) (1)
- Relation of circulating estrogens with hair relaxer and skin lightener use among postmenopausal women in Ghana (2022) (1)
- Measured body size and serum estrogen metabolism in postmenopausal women: the Ghana Breast Health Study (2022) (1)
- Prediction and clinical utility of a contralateral breast cancer risk model (2019) (1)
- Disinfection By-Products in Drinking Water and Bladder Cancer: Evaluation of Risk Modification by Common Genetic Polymorphisms in Two Case–Control Studies (2022) (1)
- Leveraging technology for health services continuity in times of COVID-19 pandemic: Patient follow-up, and mitigation of worse patient outcomes (2021) (1)
- Cross-cancer genome-wide association analysis of lung, ovary, breast, prostate and colon cancer identifies a novel cancer locus at 1q22 (2015) (0)
- rs 2735383 , located at a microRNA binding site in the 3 ’ UTR of NBS 1 , is not associated with breast cancer risk (2016) (0)
- Interplay of four genetic high risk variants for urinary bladder cancer (2018) (0)
- Abstract 944: Translational implications of the 19q12 bladder cancer GWAS signal for aggressive bladder cancer (2014) (0)
- Abstract P5-02-04: Plasma autoantibodies associated with basal-like breast cancers (2016) (0)
- Abstract 58: Associations between breast cancer susceptibility markers and terminal duct lobular unit involution in normal breast tissues among women from the Susan G. Komen for the Cure® Tissue Bank. (2012) (0)
- An unusual suspect: an uncommon human-specific synonymous coding variant within the UGT1A6 gene explains a GWAS signal and protects against bladder cancer (2011) (0)
- Abstract LB084: High cardiovascular disease mortality after central nervous system tumor diagnosis: Evidence from UK and USA population-based study (2021) (0)
- A novel functional variant in 8q24 is associated with regulation of prostate stem cell antigen (PSCA) gene expression and bladder cancer risk (2011) (0)
- Modification Of The Effect Of Disinfection Byproduct Exposure On Bladder Cancer Risk By Genetic Polymorphisms (2015) (0)
- Abstract 874: Autoantibody biomarker discovery in basal-like breast cancer using nucleic acid programmable protein array (2014) (0)
- Breast cancer risks associated with missense variants in breast cancer susceptibility genes (2022) (0)
- FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women. (2023) (0)
- 755 From Genome-wide Association Studies to Translational Genomics of Bladder Cancer (2012) (0)
- PROTEOMICS – Clinical Applications Table of Contents (2013) (0)
- Reproductive history differs by molecular subtypes of breast cancer among women aged ≤50 years in Scotland in 2009-16: A population-based retrospective cohort study (2021) (0)
- Cardiovascular Events After Primary Malignant and Non-Malignant Brain Tumour Diagnosis: A Population Matched Cohort Study in Wales (United Kingdom) (2022) (0)
- Annexin A1 expression in breast cancer: tumor subtypes and prognosis (2015) (0)
- CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers (2021) (0)
- Towards the development of non-invasive measures of breast cancer risk: image analysis of digital breast tomosynthesis mammograms and tissue lobule content. (2017) (0)
- Abstract 861: Relationships of prolactin serum levels to breast cancer risk and tumor characteristics in a population-based case-control study from Poland (2010) (0)
- Common germline polymorphisms associated with breast cancer-specific survival (2015) (0)
- Standardizing reporting of brain and central nervous system tumors in the United Kingdom. (2022) (0)
- Genome-wide association study of germline variants and breast cancer-specific mortality (2019) (0)
- Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival (2023) (0)
- Abstract 622: Reproductive factors and breast cancer risk to women in Ghana, West Africa (2019) (0)
- Title : Plasma autoantibodies associated with basal-like breast cancers Running Title : Basal-like breast cancer autoantibodies (2015) (0)
- Abstract 776: Temporal changes in mammographic breast density and breast cancer risk among women with benign breast disease (2023) (0)
- a novel candidate breast cancer susceptibility locus on (2017) (0)
- Abstract C11: Impact of pathologic specimen quality on classifying molecular subtypes of breast cancer: A pilot study from three hospitals in Ghana, Africa (2014) (0)
- Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (2022) (0)
- Cardiovascular events and venous thromboembolism after primary malignant and non-malignant brain tumour diagnosis: a population matched cohort study in Wales (United Kingdom) (2023) (0)
- Genome-wide association study of germline variants and breast cancer-speci fi c mortality (2019) (0)
- Abstract 3451: Breast cancer risk factor associations by loss of E-cadherin tumor tissue expression: A pooled analysis of 5,896 cases in 12 studies from the Breast Cancer Association Consortium (BCAC) (2016) (0)
- Urinary bisphenol A-glucuronide and postmenopausal breast cancer in Poland (2014) (0)
- Expression Association with Risk Factors , Clinical Variables , and Gene Benign Breast Tissue Composition in Breast Cancer Patients : (2014) (0)
- Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry (2016) (0)
- Abstract 3651: Parity-related molecular signatures and breast cancer heterogeneity. (2013) (0)
- Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approaches (2020) (0)
- The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (0)
- Body mass index and breast cancer survival (2017) (0)
- Abstract 1233: A novel 14-gene signature to predict response to neoadjuvant chemotherapy and endocrine treatment in breast cancer patients (2022) (0)
- Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients (2017) (0)
- Risk factors for breast cancer development by tumor characteristics among women with benign breast disease (2021) (0)
- Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of Scottish cancer registry data (2020) (0)
- Identification and characterisation of novel associations in the CASP 8 / ALS 2 CR 12 region 1 on chromosome 2 with breast cancer risk 2 3 (2014) (0)
- Abstract 4636: Breast cancer age-specific incidence rates among Ghanaian women by breast cancer risk factors: A study using census and population-based case-control study data (2020) (0)
- Abstract PO-093: Circulating tumor DNA (ctDNA) from peripheral blood is detectable among Ghanaian breast cancer patients (2020) (0)
- Title Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (2018) (0)
- Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women (2021) (0)
- Fine mapping of 14q24.1 breast cancer susceptibility locus (2011) (0)
- Abstract LB-337: Synergistic effects of twelve common genetic polymorphisms and smoking habits on absolute risk of bladder cancer (2012) (0)
- Abstract 5570: Heterogeneity of luminal breast cancer characterized by immunohistochemical expression of basal markers (2015) (0)
- Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics. (2022) (0)
- Abstract SY25-02: Double-edged “soil”: Stromal microenvironment in breast cancer development (2022) (0)
- Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus (2016) (0)
- Abstract 5290: Racial variation in terminal duct lobular unit (TDLU) involution in Chinese and Polish breast cancer patients (2017) (0)
- Abstract 1658: Post-GWAS genetic and functional studies for bladder cancer: An uncommon protective synonymous coding variant within the UGT1A6 gene explains the GWAS signal and affects cellular detoxification (2012) (0)
- Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease (2016) (0)
- Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (0)
- Reply to ‘Mosaic loss of chromosome Y in leukocytes matters’ (2018) (0)
- Abstract 4613: Cross-ancestry genome-wide association study identifies six new loci for breast cancer in women of African and european ancestry (2020) (0)
- Abstract A81: Relationships between expression of TGF-β factors and breast tumor characteristics in a population-based study from Poland (2009) (0)
- Adaptive immune receptor features related to breast cancer tissue in Kenyan patients: high immunoglobulin gene expression and high levels of gamma-delta T-cells (2023) (0)
- A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (0)
- Function and Aggressive Disease The 19 q 12 Bladder Cancer GWAS Signal : Association with Cyclin E Updated (2014) (0)
- Abstract 2783: A novel functional variant is associated with regulation of the prostate stem cell antigen (PSCA) gene and bladder cancer risk in males (2011) (0)
- P034 Smoking status, primary adult occupation and risk of recurrent urothelial bladder carcinoma: data from the cancer genome atlas (TCGA) project (2016) (0)
- Abstract A36: Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution in Caucasian and African American women: The Susan G. Komen Tissue Bank (2018) (0)
- Abstract 2320: Evaluating a polygenic risk score for breast cancer in women of African ancestry (2020) (0)
- Abstract 4283: Relationship between mammographic breast density and measures of terminal duct lobular unit involution among women diagnosed with estrogen receptor positive breast cancer (2016) (0)
- Reproductive history differs by molecular subtypes of breast cancer among women aged ≤ 50 years in Scotland diagnosed 2009–2016: a cross-sectional study (2022) (0)
- AD51B in Familial Breast Cancer (2016) (0)
- Abstract 4638: Associations of fecal microbial profiles with non-malignant breast disease and breast cancer in the Ghana Breast Health Study (2020) (0)
- OP32 Socioeconomic status and breast cancer mortality in scotland by oestrogen receptor status (2019) (0)
- Rare copy number variants (CNVs) and breast cancer risk (2021) (0)
- Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors (2017) (0)
- Abstract 71: Relationship of mammographic density and gene expression analysis of normal breast tissue surrounding breast cancer. (2012) (0)
- Abstract LB-336: Association of variant rs2046210 at 6q25.1 (ESR1) with breast cancer risk suggests heterogeneity by E-cadherin tumor tissue expression (2012) (0)
- Practice of Epidemiology Likelihood Ratio Test for Detecting Gene ( G )-Environment ( E ) Interactions Under an Additive Risk Model Exploiting G - E Independence for Case-Control Data (2012) (0)
- An unusual suspect: an uncommon human-specific synonymous coding variant within the UGT1A6 gene explains a GWAS signal and protects against bladder cancer (2011) (0)
- Abstract 826: Large-scale genome-wide association study identifies multiple novel germline susceptibility variants associated with bladder cancer risk (2021) (0)
- Differential cerebrovascular risks in glioblastoma and meningioma patients: a population-based matched cohort study in Wales (United Kingdom) (2021) (0)
- Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic Mutations: A Resource for Genetic Counseling of West African Women (2021) (0)
- Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium (2016) (0)
- Measured body size and serum estrogen metabolism in postmenopausal women: the Ghana Breast Health Study (2022) (0)
- Fine-mapping identifies two additional susceptibility 9q31.2. (2015) (0)
- Abstract 2767: Investigation of the relationship between crown-like structures and adipose tissue hormone levels among postmenopausal women with breast cancer (2015) (0)
- Cancer referrals at African Inland Church Kijabe Hospital, Kiambu County (2014-2020) and the impact of COVID-19. (2023) (0)
- Abstract P3-12-05: Genetic Variation in Prolactin and Prolactin Receptor, and Relationships with Serum Prolactin Levels and Breast Cancer Risk (2010) (0)
- Association of rs12662670 with breast cancer in Asian ER (2012) (0)
- NCMP-09. IMPACT OF TUMOUR CHARACTERISTICS AND CANCER TREATMENT ON CEREBROVASCULAR MORTALITY AFTER GLIOMA DIAGNOSIS: EVIDENCE FROM A POPULATION-BASED CANCER REGISTRY (2022) (0)
- The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti–Cancer Treatment (2023) (0)
- Polygenic Risk Scores for Prediction of Breast Cancer Risk in Women of African Ancestry: a Cross-Ancestry Approach (2021) (0)
- Discovery of structural deletions in breast cancer susceptibility genes using whole genome sequencing data from >2,000 African ancestry women (2020) (0)
- Estrogen receptor negative breast cancer incidence rates are similar in Ghanaian and Non-Hispanic Black women in the USA (2022) (0)
- Abstract 81: Studying Ghanian Cancer Genomes Using Cell-free DNA (2021) (0)
- Abstract P3-06-17: Unlocking the transcriptomic potential of formalin-fixed paraffin embedded breast cancer tissues for high-throughput genomic analysis (2019) (0)
- Reproductive Factors and Risk of Breast Cancer by Tumour Subtypes Among Ghanaian Women: A Population-Based Case-Control Study (2019) (0)
- Abstract WP15: Role Of Grade Among Glioma Patients And Risk Of Cerebrovascular Mortality: A Population-based Analysis (2022) (0)
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2020) (0)
- The impact of coding germline variants on contralateral breast cancer risk and survival (2023) (0)
- Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia (2014) (0)
- Abstract 4250: DNA methylation portraits of breast cancer in a population-based cohort. (2013) (0)
- Abstract 1818: Gene expression profiling to understand stages in breast cancer development and progression: importance of tissue sampling and context . (2013) (0)
- Genetic variation in the immunosuppression pathway genes and breast cancer: a pooled analysis of 42,510 cases and 40,577 controls from the Breast (2015) (0)
- Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia | NOVA. The University of Newcastle's Digital Repository (2014) (0)
- Breast cancer risk in women from Ghana carrying rare germline pathogenic mutations. (2022) (0)
- OP-JNCI200057 329..337 (2021) (0)
- Abstract B89: Endogenous hormone levels and lobular involution of the breast among healthy, postmenopausal women in the Komen Tissue Bank Study (2012) (0)
- Correction to: Relation of circulating estrogens with hair relaxer and skin lightener use among postmenopausal women in Ghana (2022) (0)
- BenignBreast TissueComposition inBreastCancerPatients : Association with Risk Factors , Clinical Variables , and Gene Expression (2014) (0)
- Associations of breast cancer etiologic factors with stromal microenvironment of primary invasive breast cancers in the Ghana Breast Health Study (2023) (0)
This paper list is powered by the following services:
Other Resources About Jonine Figueroa
What Schools Are Affiliated With Jonine Figueroa?
Jonine Figueroa is affiliated with the following schools:
